Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-20Clinical Trial Update: The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
A completed clinical trial investigating how a patient's smoking status impacts the effectiveness of etanercept therapy in chronic plaque ps…
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of DSXS in mild to moderate plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis [Phase 2]
Phase 2 clinical trial assessing potential adrenal suppression following treatment with DSXS in patients with plaque psoriasis; study comple…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study [Phase 2]
Phase 2 randomized trial in plaque psoriasis completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: An Open Label, Safety Study to Assess the Potential for Adrenal Suppression [Phase 2]
Phase 2 open-label safety study assessing potential adrenal suppression in plaque psoriasis; completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) [Phase 3]
Phase 3 trial comparing 122-0551 Foam to vehicle foam in plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) [Phase 3]
Phase 3 trial comparing 122-0551 foam to vehicle foam in plaque psoriasis. Study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating efficacy and safety of 122-0551 in subjects with plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating AM001 7.5% cream vs vehicle for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis [Phase 3]
Phase 3 trial comparing 122-0551 foam to vehicle foam in plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 pediatric trial assessing safety, tolerability, and pharmacokinetics of apremilast (CC-10004) in moderate-to-severe plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression [Phase 2]
Phase 2 clinical trial update on pharmacokinetics of 122-0551 and its effects on adrenal suppression in plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis [Phase 3]
Phase 3 trial update for M923 in combination with Humira in chronic plaque-type psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis [Phase 3]
A Phase 3 trial comparing tazarotene 0.05% cream to TAZORAC® (tazarotene) 0.05% cream and to placebo in plaque psoriasis has completed with …
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast [Phase 4]
Phase 4 trial evaluating the efficacy of etanercept in adults with plaque psoriasis who failed apremilast therapy has completed with results…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two dose levels of certolizumab pegol for plaque psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two doses of certolizumab pegol for plaque psoriasis has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203) [Phase 2]
Phase 2 trial comparing 188-0551 solution to vehicle in plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Natural Gels for Treatment of Plaque Psoriasis [Phase 2, Phase 3]
A clinical trial update reports Phase 2 and Phase 3 testing of Natural Gels for treating plaque psoriasis, with parapsoriasis listed as a co…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial assessing certolizumab pegol versus active comparator and placebo in plaque psoriasis; study completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment [Phase 3]
Phase 3 trial update for ixekizumab in moderate-to-severe plaque psoriasis patients naive to systemic treatment; study completed with result…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) [Phase 3]
Phase 3 study evaluating subcutaneous tildrakizumab for moderate-to-severe chronic plaque psoriasis with long-term extension; trial complete…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010) [Phase 3]
Phase 3 trial evaluating subcutaneous MK-3222 in moderate-to-severe chronic plaque psoriasis completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis [Phase 2]
Phase 2 efficacy and safety study of NP000888 in plaque psoriasis and nail psoriasis has completed. The provided snippet does not include ef…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: 4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis [Phase 3]
This four-year extension trial reports long-term efficacy and safety of secukinumab in adults with chronic plaque psoriasis. The Phase 3 stu…